Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

198
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
198
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

80
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
80
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

2.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.0K
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

129
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
129

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer.

Radiation oncology (London, England)·2022
Same author

A randomised controlled trial of pectoral nerve-2 (PECS 2) block vs. serratus plane block for chronic pain after mastectomy.

Anaesthesia·2019
Same author

A Report on the Positive Response to an Outdoor Nature Challenge of a Snow Camp for Young Liver Transplant Patients.

Transplantation proceedings·2017
Same author

Resilience after 3/11: structural brain changes 1 year after the Japanese earthquake.

Molecular psychiatry·2014
Same author

Brain structural changes as vulnerability factors and acquired signs of post-earthquake stress.

Molecular psychiatry·2012
Same author

Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.

Cytotherapy·2006

Related Experiment Video

Updated: Apr 25, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.6K

Multi-drug-resistant Staphylococcus aureus and future chemotherapy.

K Hiramatsu1, Y Katayama1, M Matsuo1

  • 1Research Center for Infection Control Science, Juntendo University, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, Japan.

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|August 31, 2014
PubMed
Summary
This summary is machine-generated.

Staphylococcus aureus is a dangerous pathogen that has developed resistance to many antibiotics, including vancomycin. This study explores the genetic basis of this multi-drug resistance and proposes new treatment strategies.

Keywords:
MRSAReverse antibiotic (RA)SCCmecmecArpoBsVISA

More Related Videos

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

24.3K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

28.9K

Related Experiment Videos

Last Updated: Apr 25, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.6K
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

24.3K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

28.9K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • Staphylococcus aureus is a common bacterium that can cause severe infections.
  • Multi-drug resistance in S. aureus, particularly Methicillin-resistant S. aureus (MRSA), is a significant global health threat.
  • The emergence of Vancomycin-intermediate S. aureus (VISA) highlights the adaptability of this pathogen.

Purpose of the Study:

  • To elucidate the genetic underpinnings of multi-antibiotic resistance in Staphylococcus aureus.
  • To propose a new therapeutic approach for combating multi-drug resistant S. aureus infections.

Main Methods:

  • Analysis of genetic factors contributing to antibiotic resistance in S. aureus.
  • Review of historical antibiotic resistance trends and clinical isolates.
  • Development of a novel treatment paradigm based on genetic insights.

Main Results:

  • Detailed description of the genetic basis for S. aureus's ability to acquire multi-drug resistance.
  • Identification of key adaptive mutations leading to resistance phenotypes.
  • Proposal of a new framework for future anti-bacterial chemotherapy.

Conclusions:

  • Understanding the genetic mechanisms of S. aureus resistance is crucial for effective treatment.
  • Novel therapeutic strategies are needed to overcome the challenge of multi-drug resistant S. aureus.
  • This research provides a foundation for developing next-generation treatments against intractable bacterial pathogens.